Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies

Beryl B. Cummings, Mark Joing, Page Bouchard, Mark Milton, Peter F Moesta, Vyas Ramanan, Andrew A. Lane, Joe Hirman, John W. Trauger, Eleftheria Maratos–Flier, Andrei Voznesensky, Igor Splawski, Amitabh V. Nimonkar, Meghan Flaherty, B. Alexander Yi, Daniel S. Meyers, François Huet, Sukhdeep K Sahambi, Denise P. Yates, Douglas Hom, Markus Hinder, Craig T. Basson, Chris O’Donnell, Evan S. Siegelman, C. Gaelyn Garrett, Joshua Lehrer‐Graiwer, Rebecca A. Juliano, Ethan J. Weiss

The Lancet · 2025

Read source ↗ All evidence

Source type: Peer-reviewed study
DOI: 10.1016/s0140-6736(25)00825-6
Catalogue ID: SNmoj446po-r5pth2

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.

How does this finding apply in a UK context?→What are the most cited records on this topic?→